Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-25 @ 3:37 AM
NCT ID:
NCT02447705
Eligibility Criteria:
Inclusion Criteria:
1. Sign inform consent
2. Age is not less than 16 years old.
3. Post liver transplantation patient for HBV-related indication.
4. Chronic hepatitis B transplant patients who are treated by lamivudine for not less than 6 months.
5. eGRF stage 2-4 patients (15\<eGFR\<90ml)
6. Stable liver function, ALT not more than 2 folds of upper limit.
Exclusion Criteria:
1. Acute rejection with increase CNI dose within a month.
2. Pregnant or nursing.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT02447705
Study Brief:
Protocol Section:
NCT02447705